“Patient-centricity” is rightfully the focus of an evolving healthcare industry and comes in many different forms. It begins behind the scenes, in the scientific and regulatory efforts to bring new drugs to market, it continues with prescriptions, adherence and as we get closer to the patient experience in day-to-day life, patient-centricity moves into co-pay andContinue reading The Missing Piece of Patient Centricity
Still waiting for the FDA to tell Pharma what we can do in Social Media? Folks, we already have our guidelines. Reading an old article last night (note: from Jan 2014) made me realize some of the real reasons behind Pharma’s struggle with social media – and it’s not because of the FDA or lack of guidance. While theContinue reading Pharma, We Already Have Our FDA Social Media Guidelines
In my eyes, we’ve only uncovered the tip of the iceberg for health and mobile, it has always just been a matter of avoiding the giant block of ambiguous ice that lives underneath that tip – but with the proper navigation, the opportunity for innovation and success is unlimited. The caution comes mostly in the fear of riskContinue reading Pharma Mobile Apps Are Not Dead and Kudos Sanofi, But More Can Be Done
“Android Wear” looks very cool. There is no doubt about the future of “wearables” as an integral part of our lives. As a tech lover, I am extremely happy that companies like Google are exploring our future to the point of creating devices to test ideas in the real world (Google Glass) and that wearables areContinue reading Android Wear – How Much of Our Data is a Wearable Worth?
